ANTONIO EDDINGS: Open Payments
NPI 1821491929 · MADISON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,526 in 62 payments from 10 companies in 2025. Trend: 2023 $1,158 · 2024 $815 · 2025 $1,526
Food & beverage: $1,514Education: $12
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 20 | $419 |
| Neurocrine BioSciences, Inc. | 5 | $233 |
| Otsuka America Pharmaceutical, Inc. | 12 | $193 |
| Axsome Therapeutics, Inc. | 7 | $183 |
| E.R. Squibb & Sons, L.L.C. | 3 | $154 |
| Alkermes, Inc. | 4 | $95 |
| Lundbeck LLC | 4 | $91 |
| ABBVIE INC. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Exact Sciences Corporation | 2 | $48 |
Products named: FANAPT, REXULTI, INGREZZA, Auvelity, COBENFY, HETLIOZ, ARISTADA, CAPLYTA.
Industry payments across TN — which companies pay providers there.
